7,647.75

+33.75

+0.44%

52,080.00

+162.00

+0.31%

28,776.00

+242.00

+0.85%

Russell 2000 Futures

2,835.60

+14.30

+0.51%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,917.20

+18.30

+0.47%

78,049.48

+190.88

+0.25%

Crude Oil Dec 26

100.69

-3.43

-3.29%

US Private Equity

10,850.63

-82.20

-0.75%

Annovis Bio Enrolls Over 850 Patients for Its Next Alzheimer's Disease Trial

NYSE

July 7, 2026

ANVS
+10.78%

Annovis Bio's Sarah MacCallum and Cheng Fang joins Ashley Mastronardi on NYSE Live to discuss the next alzheimers disease trial

Terms and Privacy Policy

Your Privacy Choices

Mobilize your Website

View Site in Mobile | Classic

Share by: